Abstract

Large-scale synthesis of active recombinant porcine luteinizing hormone/chorionic gonadotropin receptor (pLHR) is required for biophysical and structural studies. This study was undertaken to improve expression of the corresponding cDNA already obtained with a number of other systems, (i) by turning to cells from mammalian origin able to perform adequate glycosylation, (ii) by using an expression vector containing the acknowledged high-performance rabbit WAP gene upstream region together with transcription and translation stimulating sequences, and (iii) by expressing natural splicing variants. Selection of the transfected HC11 cells was performed in terms of pLHR expression using specific radioligand binding and immunoradiometric assays. Secretion of pLHR ectodomain into the culture medium of the HC11 clones was quantified, and reached 70 ng/ml, which represents the highest active amount ever produced. However, this level of expression was relatively low in comparison to that currently observed with bGH cDNA used as reporter gene. Additional investigations were performed in order to gain further insight into the limitation of the production of pLHR relative to bovine or human growth hormone using the same expression system. A high number of copies of cDNA in the genome of HC11 cells was found, provided that an antibiotic selection pressure was maintained to avoid drifting. The low mRNA levels detected for pLHR relative to hGH mRNAs correlate well with the relative protein production levels. They could arise from poor stability of mRNAs, a fact already observed for the natural receptor in gonadal cells. These results thus constitute a promising indicator for possible expression of pLHR in the milk of transgenic animals.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.